The Biop probe offers immediate diagnosis of cervical cancer, creating better,faster and cheaper medicine in the West,saving 250k lives in the developing world.
Biop is developing a platform for the identification, diagnosis and classification of epithelium based cancers. Our first product is focused on cervical cancer, a $2B screening market.
Biop's technology is based on 5 unique optical technologies, and our business model is based on diagnosis as a service.